Molina Healthcare Inc header image

Molina Healthcare Inc

MOH

Equity

ISIN US60855R1005 / Valor 1538184

New York Stock Exchange, Inc (2024-09-18)
USD 355.15+0.59%

Molina Healthcare Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Molina Healthcare Inc is a prominent health care provider that specializes in offering high-quality, affordable health care services primarily to individuals and families who are beneficiaries of government-sponsored health care programs. Founded in 1980 with a single clinic in Long Beach, the company has significantly expanded its operations over the past four decades. It now operates 19 health plans across the United States, catering to the needs of over 5.1 million members. Molina Healthcare is dedicated to addressing the comprehensive health needs of its members, including their physical, social, and emotional well-being, through a community-based approach tailored to each individual's requirements. The company's growth is also marked by its initiative, the MolinaCares Accord, launched in 2020, which aims to enhance access to health care for its members by making substantial investments in the communities it serves.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (20.08.2024):

Premium Revenue

Premium revenue for Molina Healthcare Inc. in the second quarter of 2024 was approximately $9.4 billion, marking a 17% increase year over year. This growth was driven by new contract wins, acquisitions, and expansion within the company's existing footprint, although it was partially offset by the impact of Medicaid redeterminations.

Net Income

Molina Healthcare Inc. reported GAAP net income of $5.17 per diluted share for the second quarter of 2024, a 3% decrease compared to the same period in 2023. However, the adjusted net income was $5.86 per diluted share, reflecting a 4% increase year over year.

Medical Care Ratio (MCR)

The consolidated Medical Care Ratio (MCR) for Molina Healthcare Inc. in the second quarter of 2024 was 88.6%. This ratio indicates the company's continued focus on managing medical costs. The Medicaid MCR was 90.8%, influenced by a one-time, retroactive premium adjustment and new Medicaid plans, while the Medicare and Marketplace MCRs were 84.9% and 71.6%, respectively.

General and Administrative Expense Ratio

For the second quarter of 2024, Molina Healthcare Inc. reported a General and Administrative (G&A) expense ratio of 7.0%, with an adjusted G&A ratio of 6.9%. These figures reflect the company's efficiency in managing administrative costs relative to its revenue.

2024 Guidance

Molina Healthcare Inc. reaffirmed its full-year 2024 guidance, expecting premium revenue to be approximately $38 billion, a 17% increase from 2023. The company also anticipates adjusted earnings per diluted share to be at least $23.50, representing a 13% growth over the previous year. The company expects Medicaid pressures to be offset by higher net investment income and contract extensions in Virginia and Florida.

Summarized from source with an LLMView Source

Key figures

7.95%1Y
27.7%3Y
210%5Y

Performance

29.0%1Y
29.0%3Y
35.7%5Y

Volatility

Market cap

20812 M

Market cap (USD)

Daily traded volume (Shares)

110,798

Daily traded volume (Shares)

1 day high/low

358.43 / 352.97

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Shionogi Seiyaku KK
Shionogi Seiyaku KK Shionogi Seiyaku KK Valor: 763280
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%JPY 6,303.00
Ypsomed Holding AG
Ypsomed Holding AG Ypsomed Holding AG Valor: 1939699
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.95%CHF 417.50
Medacta Group Ltd
Medacta Group Ltd Medacta Group Ltd Valor: 46852522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%CHF 122.40
COLTENE HOLDING AG
COLTENE HOLDING AG COLTENE HOLDING AG Valor: 2534325
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.65%CHF 47.60
Insulet Corp
Insulet Corp Insulet Corp Valor: 2941247
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.24%USD 236.11
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.35%USD 57.70
Agenus Inc
Agenus Inc Agenus Inc Valor: 134326284
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.89%USD 6.05
EssilorLuxottica SA
EssilorLuxottica SA EssilorLuxottica SA Valor: 497537
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.34%EUR 204.80
Eurofins Scientific SE
Eurofins Scientific SE Eurofins Scientific SE Valor: 58317129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%EUR 52.34
Dermapharm Holding SE
Dermapharm Holding SE Dermapharm Holding SE Valor: 40166352
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.43%EUR 35.10